Your browser is no longer supported. Please, upgrade your browser.
HOOKIPA Pharma Inc.
Index- P/E- EPS (ttm)-1.63 Insider Own0.40% Shs Outstand25.66M Perf Week-0.86%
Market Cap373.76M Forward P/E- EPS next Y-2.25 Insider Trans-35.18% Shs Float14.38M Perf Month-0.94%
Income-41.90M PEG- EPS next Q-0.58 Inst Own57.10% Short Float9.03% Perf Quarter0.43%
Sales18.00M P/S20.76 EPS this Y-277.10% Inst Trans17.78% Short Ratio8.61 Perf Half Y33.53%
Book/sh3.59 P/B3.22 EPS next Y-21.00% ROA-31.30% Target Price- Perf Year-3.75%
Cash/sh2.53 P/C4.57 EPS next 5Y4.80% ROE-39.60% 52W Range5.80 - 13.68 Perf YTD4.15%
Dividend- P/FCF- EPS past 5Y- ROI-41.50% 52W High-15.57% Beta-
Dividend %- Quick Ratio5.70 Sales past 5Y- Gross Margin- 52W Low99.14% ATR0.64
Employees85 Current Ratio5.70 Sales Q/Q100.00% Oper. Margin- RSI (14)46.48 Volatility5.15% 5.19%
OptionableYes Debt/Eq0.05 EPS Q/Q-18.20% Profit Margin- Rel Volume1.20 Prev Close12.00
ShortableYes LT Debt/Eq0.05 Earnings- Payout- Avg Volume150.68K Price11.55
Recom1.60 SMA20-3.05% SMA50-0.98% SMA2006.57% Volume181,917 Change-3.75%
Nov-03-20Initiated Truist Buy $21
Oct-26-20Initiated JMP Securities Mkt Outperform $19
Oct-19-20Resumed H.C. Wainwright Buy $16
Sep-27-19Initiated H.C. Wainwright Buy $15
May-13-19Initiated RBC Capital Mkts Outperform $23
May-13-19Initiated BofA/Merrill Buy $17
Mar-04-21 07:00AM  
Mar-03-21 07:00AM  
Feb-27-21 03:49AM  
Feb-16-21 07:00AM  
Jan-20-21 09:55AM  
Dec-11-20 04:20PM  
Dec-08-20 10:00PM  
Dec-07-20 11:33PM  
Nov-30-20 06:00AM  
Nov-18-20 10:23AM  
Nov-15-20 08:26AM  
Nov-12-20 07:39AM  
Nov-11-20 07:00AM  
Nov-03-20 07:00AM  
Oct-29-20 07:30AM  
Oct-26-20 10:08AM  
Oct-21-20 10:32AM  
Oct-19-20 08:00AM  
Sep-16-20 07:45AM  
Sep-09-20 07:30AM  
Aug-13-20 10:35AM  
Aug-06-20 12:30PM  
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
Jul-23-20 03:24PM  
Jun-22-20 07:15AM  
Jun-19-20 07:00AM  
Jun-17-20 07:00AM  
Jun-12-20 02:04PM  
Jun-11-20 08:34AM  
May-26-20 07:30AM  
May-17-20 09:31AM  
May-14-20 08:15AM  
May-07-20 12:30PM  
May-04-20 07:00AM  
Apr-29-20 07:00AM  
Apr-21-20 07:00AM  
Apr-19-20 10:33AM  
Mar-19-20 07:00AM  
Mar-10-20 08:15AM  
Feb-18-20 08:00AM  
Jan-15-20 09:53AM  
Jan-06-20 07:00AM  
Dec-30-19 07:30AM  
Dec-20-19 02:27PM  
Nov-25-19 08:00AM  
Nov-12-19 04:01PM  
Nov-04-19 08:00AM  
Oct-31-19 08:15AM  
Sep-25-19 08:30AM  
Sep-19-19 08:55AM  
Aug-29-19 08:30AM  
Aug-12-19 04:01PM  
Jul-19-19 01:37PM  
Jul-17-19 10:06AM  
Jul-12-19 07:58AM  
Jul-11-19 04:37PM  
Jun-10-19 09:10AM  
May-20-19 04:01PM  
May-08-19 03:47AM  
Apr-25-19 08:30AM  
Apr-18-19 11:01AM  
Apr-17-19 10:49PM  
Apr-14-19 09:53AM  
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immune-therapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Matushansky IgorChief Medical OfficerDec 17Option Exercise0.1048,9884,89993,881Dec 18 04:04 PM
Matushansky IgorChief Medical OfficerDec 17Sale11.7427,979328,34364,253Dec 18 04:04 PM
Matushansky IgorChief Medical OfficerDec 16Option Exercise0.106406456,774Dec 18 04:04 PM
Matushansky IgorChief Medical OfficerDec 16Sale11.703804,44656,394Dec 18 04:04 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerOct 02Sale10.003003,0003,906,194Oct 06 04:01 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerSep 15Sale12.6141,597524,4773,906,494Sep 17 04:02 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerJul 20Sale11.9412,483149,1023,948,091Jul 22 04:03 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerJun 29Sale11.783,28038,6283,960,574Jul 01 04:16 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerJun 29Sale11.783,28038,6283,960,574Jul 22 04:03 PM